HIHrishik Iqbal

Hrishik Iqbal

*This is an algorithmically generated author record based on publicly available information.

Hrishik Iqbal has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oxidative Stress Induced Thrombosis and Hypercholesterolemic Condition in COVID-19 Infection

    by Ashfaq Ahmed, Hrishik Iqbal, Md Shaki Mostaid, Afroza Zannat, Srikumar Chakravarthi, Nikolaos Syrmos

    The COVID-19 pandemic, caused by SARS-CoV-2, has emerged as a global health crisis, with severe disease and mortality disproportionately affecting individuals with comorbidities such as cardiovascular disease, diabetes, obesity, and immunosuppression. These conditions are associated with elevated basal reactive oxygen species (ROS) levels, predisposing patients to oxidative stress, systemic inflammation, endothelial dysfunction, and thrombotic complications. SARS-CoV-2 infection further exacerbates ROS generation via dysregulation of the renin–angiotensin system, NADPH oxidase activation, and immune-mediated neutrophil and macrophage responses, contributing to vascular injury, cytokine storm, and acute respiratory distress syndrome (ARDS). Hypercholesterolemic patients are particularly vulnerable, as oxidized LDL (OxLDL) enhances ROS production, promotes neutrophil extracellular trap formation, and accelerates thrombosis, further compounding COVID-19 severity. COVID-19–associated coagulopathy is characterized by elevated D-dimer, von Willebrand factor, and platelet activation, reflecting systemic hypercoagulability and multiorgan involvement. Therapeutically, targeting oxidative stress represents a promising strategy. Statins exhibit cholesterol-lowering and immunomodulatory effects, potentially reducing thrombotic risk. Nrf2 activators, glutathione, and N-acetylcysteine enhance endogenous antioxidant defenses, mitigate inflammation, and preserve endothelial integrity. Micronutrients such as vitamins C, D, E, and selenium further support redox homeostasis and immune function. Collectively, in this narrative review we have shown that understanding the interplay between oxidative stress, thrombosis, hypercholesterolemia, and immune dysregulation may inform preventive and therapeutic strategies to improve outcomes in high-risk COVID-19 patients. Clinical trials are warranted to validate the efficacy of these interventions.

  • Open Access

    A Systematic Review of Regional Practices and Nutraceutical Management Strategies in the treatment of Dengue Fever

    by Hassan Sazu, Atikah Islam Chowdhury, Hrishik Iqbal, Abul Hassan, Joti Devi, Nikolaos Syrmos

    Dengue fever (DF), one of the common mosquito-borne viral diseases in humans, is still a serious public health problem throughout the world with special emphasis on tropical and subtropical areas. Though there are significant morbidity and mortality, treatments are mainly supportive; thus, additional approaches that may decrease disease severity are warranted. There is accumulating evidence that micronutrient status may potentially affect immune responses and clinical outcome in DF, thus supporting more general observations of nutritional modulation of susceptibility to, disease progression or outcome from infectious diseases. To assess this possibility, we considered the literature on micronutrient supplementation for DF patients. Vitamin C, Vitamin D, vitamin E and zinc were reported in some studies to potentially reduce recovery time, improve platelet trends and decrease severity of illness. In contrast, folic acid did not have any significant effects on clinical end points. However, as the available literature is fraught with obvious weaknesses such as small sample size, differing results between studies and an inadequate assessment of patients' nutritional status at the outset, any clinical recommendations are weakened. Although vitamins D and E have shown promise in preliminary trials, the existing body of evidence is not clear and coherent. This review addresses the increasing attention on micronutrient interventions in DF as well as the necessity of good quality randomized controlled trials that provide better exposure about their therapeutic effects and evidence-based recommendations.


  • Open Access

    Bortezomib in multiple myeloma management

    by Hrishik Iqbal, Mohammad Nazmul Islam, Srikumar Chakravarthi, Mohammad Chand Jamali, Rezwan Ahmed Mahedi, Sadia Afrin, Pujita Roy, Fahadul Alam, Md.SHajalal Reza, Νikolaos Syrmos

    Multiple myeloma (MM) is a hematologic malignancy characterized by the uncontrolled proliferation of plasma cells, leading to complications such as bone lesions, renal dysfunction, and immune suppression. Over the past three decades, its incidence has risen significantly, attributed to factors such as aging populations and improved diagnostic methods. Treatment strategies have evolved considerably, transitioning from alkylating agents and high-dose chemotherapy to targeted therapies, including proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs). Bortezomib, a first-in-class PI, has revolutionized MM management by inhibiting proteasome activity, thereby inducing apoptosis in malignant plasma cells. This review evaluates the efficacy, safety, and clinical applications of bortezomib, both as monotherapy and in combination with dexamethasone, IMiDs, and conventional chemotherapies. Key clinical trials, such as VISTA and SUMMIT, demonstrate its superiority over traditional regimens, improving response rates and survival outcomes. However, its use is associated with adverse effects, including peripheral neuropathy, hematologic toxicities, and gastrointestinal disturbances, necessitating dose modifications and supportive care. Emerging combinations with monoclonal antibodies and novel agents further enhance therapeutic potential, though optimal sequencing remains under investigation. Systematic literature search was performed using PubMed and Cochrane to identify relevant studies on the applications of bortezomib. The search was inclusive of all publications up to May 2025, without restriction by publication year, to ensure a thorough review of research on bortezomib. Studies focusing on multiple myeloma (MM) and the efficacy of bortezomib were prioritized. A broad set of keywords was employed reflecting the diverse applications of bortezomib in MM treatment. The search strategy was designed to capture a wide range of relevant studies. By synthesizing evidence from 77 studies, this review highlights bortezomib’s pivotal role in MM treatment while addressing challenges in toxicity management. Future research should focus on refining combination strategies and minimizing side effects to maximize long-term patient outcomes.

  • Open Access

    Human Metapneumovirus: A Critical Review of Its Impact on the Immune System and Clinical Implications

    by Syed Mahmood Shahidul Islam, Nourjahan Laskar, Md.SHajalal Reza, Faisal Ahmed, Hrishik Iqbal, Lemar Cardenas De Guia, Nikolaos Syrmos

    Human Metapneumovirus (HMPV) became known in 2001 as a major respiratory pathogen which triggers acute respiratory tract infections (ARTIs) in the population with particular impact on infants and elderly patients and individuals with impaired immunity. HMPV was recently identified but retrospective analyses show this virus has existed unnoticed throughout previous decades starting from the 1950s. The respiratory tract pathogen HMPV exists within the Pneumoviridae family with genomic and structural relationships to respiratory syncytial virus (RSV). The virus manifests differently from delicate upper respiratory conditions to dangerous bronchiolitis and pneumonia within the lower respiratory system. Medical practitioners discover it difficult to identify HMPV due to identical viral symptoms but RT-PCR now enhances testing precision. HMPV has a seasonal pattern which reaches its peak during late winter and spring through airborne respiratory droplet transmission. Most people acquire the virus before their fifth year but continued infections happen as natural protection weakens so there remains an urgent need to develop safe treatments and vaccines against HMPV. FDA-approved antiviral drugs along with vaccines do not exist for treatment so healthcare professionals must provide supportive care only. Studies of HMPV's spread have improved yet scientists have not resolved fundamental questions about lineage immunity protection and virus immune evasion behaviors and persistent immune responses. The prevention of HMPV transmission requires proper hand hygiene practice together with respiratory etiquette. Multidisciplinary research needs continuous investigation because it helps tackle the worldwide burden of HMPV while developing specific prevention methods for this enduring public health threat that affects vulnerable populations.

  • Open Access

    Current Trends and Future Prospects of Artificial Intelligence in Transforming Radiology

    by Rezwan Ahmed Mahedi, Hrishik Iqbal, Raiyan Azmee, Marzan Azmee, Fatiha Jakir, Mufassir Ahmad Nishan, Mohammed Burhan Uddin, Sadia Afrin

    Artificial intelligence (AI) has rapidly transformed numerous industries, including medicine, with radiography standing to benefit significantly from its capabilities. AI enhances diagnostic accuracy, reduces errors, and improves patient care by leveraging large datasets from digital radiographs commonly used in medical and dental practices. Despite these advantages, the impact of AI on image acquisition and radiographer workflows remains underexplored in radiography literature. This review aims to evaluate the effects of AI on radiographic practices, address regulatory challenges, and explore its integration into educational frameworks for radiologists and radiographers. It highlights AI's role in automating tasks, enhancing diagnostic precision, and improving clinical decision-making. A systematic literature search was conducted using PubMed and Google Scholar up to December 2024, with terms including "artificial intelligence," "machine learning," "deep learning," "radiography," and "diagnostic imaging." Seventy-seven peer-reviewed articles and conference papers focusing on AI applications in digital dental radiography were analyzed to extract data on AI methodologies and their potential applications. The findings reveal that AI-powered solutions enhance efficiency in complex imaging tasks, such as lesion identification and triage in mammography, and real-time assessments in cross-sectional imaging, reducing the need for re-scans and increasing patient throughput. However, widespread adoption faces obstacles related to ethical and legal concerns, including data privacy, algorithmic bias, and the need for transparency. While AI demonstrates significant potential to automate workflows, improve diagnostic accuracy, and optimize patient care in radiography, challenges related to human oversight, professional adaptation, and regulatory compliance must be addressed. Further research is needed to fully understand AI’s impact on radiography and to maximize its clinical utility.